Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom

Toxicon

Volumn 57, Issue 1, 2011, Pages 53-59

  Ruha, Anne Michelle ^a,b,c,d   Curry, Steven C ^a,b,c,d   Albrecht, Clay ^a,c   Riley, Brad ^e   Pizon, Anthony ^f  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b MARICOPA MEDICAL CENTER   (United States)

^c PHOENIX CHILDREN'S HOSPITAL   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antivenom; Coagulopathy; Rattlesnake; Recurrence; Thrombocytopenia

Indexed keywords

SNAKE VENOM ANTISERUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD TOXICITY; CHILD; CONTROLLED STUDY; ENVENOMATION; FEMALE; HUMAN; HYPOFIBRINOGENEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SNAKEBITE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIVENINS; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; CROTALID VENOMS; CROTALUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; MALE; MIDDLE AGED; RECURRENCE; SNAKE BITES; THROMBOCYTOPENIA; YOUNG ADULT;

OVIS;

EID: 78650677804     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.09.014     Document Type: Article

References (11)

1. Boyer L.V., Seifert S.A., Clark R.F., et al. Recurrent and persistent coagulopathy following pit viper envenomation. Arch. Intern. Med. 1999, 159(7):706-710.
2. Boyer L.V., Seifert S.A., Cain J.S. Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 2. Guidelines for clinical management with crotaline fab antivenom. Ann. Emerg. Med. 2001, 37(2).
3. CroFab package insert (accessed on 1 July 2010). http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM117573.pdf.
4. Dart R.C., Seifert S.A., Carrol L., et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann. Emerg. Med. 1997, 30(1):33-39.
5. Dart R.C., Seifert S.A., Boyer L.V., et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch. Intern. Med. 2001, 161(6):2030-2036.
6. Johnson P.N., McGoodwin L., Banner W. Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children. Emerg. Med. J. 2008, 25(12):793-798.
7. Offerman S.R., Bush S.P., Moynihan J.A., Clark R.F. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Pediatrics 2002, 110:968-971.
8. Ruha A.M., Curry S.C., Beuhler M., et al. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann. Emerg. Med. 2002, 39(6):609-615.
9. Stanford C.F., Olsen D., Bogdan G.M., Dart R.C. Complications of crotaline antivenom therapy in the United States. Clin. Toxicol. 2005, 43(6):708. (abstract).
10. Stanford C.F., Richardson W.H., Bush S.P., et al. Crotaline snakebite management with Fab antivenom in pediatric patients. Ann. Emerg. Med. 2006, 48(4):94. (abstract).
11. Tanen D., Ruha A., Graeme K., Curry S. Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary referral center in central Arizona. Acad. Emerg. Med. 2001, 8(2):177-182.